ORCHID Trial of Olaparib Monotherapy Could Lay Groundwork for Investigating PARP Inhibitors in Advanced RCC

Yasser Mohamed Ali Ged, MBBS, highlights the early efficacy seen in patients with renal cell carcinoma with BAP1 mutations and next steps for the ORCHID trial.

Related Keywords

Maryland ,United States ,Yasser Mohamed Ali ,Kidney Cancer Research Program ,Kidney Cancer Research ,Yasser Mohamed Ali Ged ,Cancer Research ,Johns Hopkins Medicine ,